Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-002707
Filing Date
2022-04-15
Accepted
2022-04-15 10:48:42
Documents
38
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nunzia_i10k-123121.htm   iXBRL 10-K 455709
2 CERTIFICATION nunzia_ex3101.htm EX-31.1 8022
3 CERTIFICATION nunzia_ex3102.htm EX-31.2 7335
4 CERTIFICATIONS nunzia_ex3201.htm EX-32.1 4823
  Complete submission text file 0001683168-22-002707.txt   2172110

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nunz-20211231.xsd EX-101.SCH 19149
6 XBRL CALCULATION FILE nunz-20211231_cal.xml EX-101.CAL 23193
7 XBRL DEFINITION FILE nunz-20211231_def.xml EX-101.DEF 79162
8 XBRL LABEL FILE nunz-20211231_lab.xml EX-101.LAB 159347
9 XBRL PRESENTATION FILE nunz-20211231_pre.xml EX-101.PRE 132005
32 EXTRACTED XBRL INSTANCE DOCUMENT nunzia_i10k-123121_htm.xml XML 180435
Mailing Address 1627 WEST 14TH STREET LONG BEACH CA 90813
Business Address 1627 WEST 14TH STREET LONG BEACH CA 90813 714-609-9117
NUNZIA PHARMACEUTICAL Co (Filer) CIK: 0000886093 (see all company filings)

EIN.: 870442090 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39175 | Film No.: 22829288
SIC: 8741 Services-Management Services